The Indian Pharmacovigilance Day 2017 conference was recently held in Hyderabad. Dr J Vijay Venkatraman, MD and CEO, Oviya MedSafe was nominated as the Chair. The conference was sponsored by Oviya MedSafe and had Express Pharma, Life Science World and CIMS as its media partners. The conference started with a welcome address by Enrico Pedroni, MD, EasyB, Italy, followed by Dr Venkatraman’s address as the Chair to the delegates about the nature and purpose of the conference. Dr Ammar Raza S spoke about ‘Changing Regulatory Market Landscape in Emerging Countries: Impact on Pharmacovigilance,’ which was followed by Dr Arani Chatterjee, who gave a speech on ‘Vaccine Vigilance – An Overview.’
The next session was Higher Functions in Pharmacovigilance. Dr Nitu Sinha spoke on the topic ‘Drug Safety in Biosimilars’ followed by Dr Mamtha B Nair’s seamless presentation on the operational topic “PADER Vs PBRER – A Comparative Analysis of Aggregate Reports.’ The session ended with the speech by Dr Ankur Arora titled ‘Safety Signal Detection: Do reporting Biases Matter in Today’s World?’
The audience were given an overview of the future of pharmacovigilance by Dr Vivek Ahuja, who deliberated on ‘Automation in ICSR processing – Is Artificial Intelligence the Paradigm Shift?’ Dr SD Sinha spoke about ‘Global Pharmacovigilance in Indian Multinational Pharmacovigilance Companies.’
The colloquium titled ‘Operational Excellence in Pharmacovigilance Outsourcing – Pros & Cons’ was moderated by Dr Venkatraman, with the speakers being Dr PS Karthik Babu representing the pharma industry and Soumya Padhy representing the pharmacovigilance service provider industry.
Comments are closed.